Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Long intergenic non-protein coding RNA 1404 (LINC01404) is a human long intergenic non-coding RNA (lincRNA) gene, meaning it produces an RNA transcript longer than 200 nucleotides that does not code for protein and does not overlap with protein-coding genes[1][3][5]. LincRNAs such as LINC01404 are thought to play regulatory roles in chromatin remodeling, gene expression, and RNA stability, often with tissue specificity, and may act via diverse mechanisms including functioning as enhancers or through interactions with chromatin[3]. While thousands of lincRNAs are annotated in the human genome, only a small subset have well-characterized functions or disease associations; LINC01404 itself is not yet functionally characterized or established as a therapeutic target[1][3][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Long intergenic non-protein coding RNA 1404 (LINC01404).